Featured

Ken Paxton Attempts to Block Kenvue Dividend Amid Tylenol Marketing Lawsuit

Attorney General Ken Paxton (R) has filed a motion to stop Kenvue, the manufacturer of Tylenol, from paying a scheduled November 26 dividend that he believes would “drain the company of hundreds of millions of dollars” needed to compensate Texans for alleged illegal and unethical conduct.

The motion follows a lawsuit filed last week by Attorney General Paxton against Kenvue and its former parent company, Johnson & Johnson, accusing them of deceptively marketing Tylenol to pregnant women despite being aware of potential risks linked to acetaminophen, the drug’s active ingredient. The lawsuit alleges that prenatal exposure to acetaminophen increases the likelihood of Autism Spectrum Disorder (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) in children.

That lawsuit came after Health and Human Services Secretary Robert F. Kennedy, Jr. (I) and President Donald Trump (R) targeted Tylenol.

The Texas attorney general is also seeking to hold Johnson & Johnson accountable for what he described as an “illegal corporate spinoff” of Kenvue designed to shield the company from financial liability.

In a statement, he railed against the drug manufacturers, vowing, “I will not allow Big Pharma to ruin the lives of Texans with their lies and then refuse to pay the bill when it’s brought to account.” “Kenvue very well may be insolvent because of its own reckless actions, and it should no longer pay fraudulent dividends as a way to avoid paying future civil penalties.”

According to Attorney General Paxton, Kenvue faces potential legal exposure in the billions of dollars for its “deeply unethical and unlawful behavior.” His motion requests that the court bar the company from issuing any dividends or making non-ordinary-course asset transfers until a final judgement is rendered.

He is also seeking an injunction to stop what he calls Kenvue’s “illegal and misleading marketing practices,” saying the action will help ensure the company pays Texas for putting profits ahead of the health of Texans.

Daniel Molina

Daniel Molina is a managing editor and legislative correspondent with a decade of experience covering the evolving political landscape of the American South and Southwest.

Recent Posts

New THC Rules Are Coming to Texas July 31: What to Know

Starting July 31, Texas is reinstating its ban on delta-8 and other THC isomers that…

58 minutes ago

Robert S. Howden Sworn In as 116th Secretary of State of Texas

Gov. Greg Abbott swore in Robert S. Howden as the 116th Secretary of State of…

1 hour ago

ASP Isotopes Subsidary, Texas A&M Partner on Nuclear Fuel Research

ASP Isotopes subsidiary Quantum Leap Energy has signed a research agreement with the Texas A&M…

2 hours ago

Texas Launches Rural Hospital Officers Academy to Support Rural Health Care Leaders

The Texas Health and Human Services Commission (HHSC) is creating the Rural Hospital Officers Academy…

3 hours ago

Michael McCaul Pushes Russia Sanctions, Iran Strategy, and SAVE America Act

Congressman Michael McCaul (R) said passing tougher sanctions on Russia would honor the legacy of…

4 hours ago

AI Chip Exports to China Face Bipartisan Pushback on Capitol Hill

Lawmakers scrutinized the Trump administration’s AI Action Plan on Capitol Hill, questioning whether its export…

4 hours ago